Edmond De Rothschild Holding S.A. Sarepta Therapeutics, Inc. Transaction History

Edmond De Rothschild Holding S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$63.15 - $90.42 $5.46 Million - $7.82 Million	-86,510 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$77.28 - $99.42 $1.58 Million - $2.03 Million	-20,450 Reduced 19.12%	86,510 $7.79 Million
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $2.15 Million - $3.01 Million	32,600 Added 43.84%	106,960 $9.89 Million
Q2 2021 Aug 11, 2021	BUY	$69.38 - $86.75 $5.16 Million - $6.45 Million	74,360 New	74,360 $5.78 Million

531

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.68B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.